List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 37357 studies with search of:   United States
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
21 Completed A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
Condition: Breast Neoplasms
Intervention: Drug: SU011248
22 Terminated A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care
Condition: Carcinoma, Hepatocellular
Intervention: Drug: DENSPM (diethylnorspermine)
23 Active, not recruiting Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine Carcinosarcoma
Condition: Sarcoma
Intervention: Drug: imatinib mesylate
24 Recruiting Two Dose Levels of Capecitabine With Docetaxel in Treating Women With Locally Advanced or Metastatic Breast Cancer That Has Not Responded to Previous Anthracycline-Based Chemotherapy
Condition: Breast Cancer
Interventions: Drug: capecitabine;   Drug: docetaxel
25 Active, not recruiting TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1
Condition: HIV Infections
Intervention: Drug: TNX-355
26 Active, not recruiting Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: pemetrexed disodium
27 Completed Modafinil for the Treatment of Cocaine Dependence - 1
Condition: Cocaine-Related Disorders
Intervention: Drug: Modafinil
28 Completed ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer
Conditions: Pancreatic Cancer;   Adenocarcinoma
Intervention: Drug: ARQ 501 in combination with gemcitabine
29 Completed Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: Adalimumab
30 Completed A New Oral Treatment For Type II Diabetes Mellitus
Condition: Non-Insulin-Dependent Diabetes Mellitus
Intervention: Drug: GW0823093
31 Recruiting Therapy for Pediatric Hodgkin Lymphoma
Condition: Hodgkins Lymphoma
Interventions: Drug: VAMP Chemotherapy (Favorable Risk);   Drug: Stanford V Chemotherapy (Unfavorable Risk);   Procedure: Radiation therapy
32 Active, not recruiting Ophthalmologic Safety Study of Pramipexole IR Versus Ropinirole in Early Parkinson's Disease Patients
Condition: Parkinson Disease
Interventions: Drug: pramipexole IR;   Drug: ropinirole
33 Completed Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee
Condition: Osteoarthritis, Knee
Intervention: Drug: GW406381
34 Completed A Placebo-Controlled Study of Safety and Effectiveness of Myozyme in Patients With Late-Onset Pompe Disease
Conditions: Pompe Disease (Late-Onset);   Glycogen Storage Disease Type II (GSD-II);   Acid Maltase Deficiency Disease;   Glycogenosis 2
Interventions: Drug: Myozyme (alglucosidase alfa);   Drug: Placebo
35 Enrolling by invitation A Open Label Study of a Flexible Dose of Brivaracetam in Subjects 16 Years or Older Suffering From Epilepsy
Condition: Epilepsy
Intervention: Drug: Brivaracetam (ucb 34714)
36 Completed Pharmacokinetic Evaluation of Testosterone Gel (1%)
Conditions: Primary or Secondary Hypogonadism;   Constitutional Delay in Growth and Puberty (CDGP)
Intervention: Drug: Testosterone Gel (1%)
37 Recruiting Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer
Conditions: Hepatic Metastases;   Colorectal Cancer
Interventions: Drug: Bevacizumab HAI plus systemic chemotherapy;   Drug: HAI plus systemic chemotherapy
38 Completed A Study of AT1001 in Patients With Fabry Disease
Condition: Fabry Disease
Intervention: Drug: AT1001 (migalastat hydrochloride)
39 Active, not recruiting Safety and Efficacy of Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Methoxsalen;   Procedure: Extracorporeal Photopheresis
40 Completed An Open-Label, Prospective, Randomized, Multi-Center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.
Conditions: Cadaveric Donor Renal Transplantation;   Acute Renal Allograft Rejection;   Induction Therapy
Intervention: Drug: Thymoglobulin [Anti-thymocyte Globulin (rabbit)]

Previous Page (1-20) Studies Shown (21-40) Next (41-60)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services